TD Cowen analyst Oliver Chen lowered the firm’s price target on Beauty Health (SKIN) to $1.50 from $2 and keeps a Hold rating on the shares. The company updated its model to show negative revenue trends will persist but infrastructure is progressing.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SKIN:
- Cautious Optimism Amidst Market Challenges: Beauty Health’s Hold Rating Explained
- Hold Rating for Beauty Health Amid Strong Sales and Macroeconomic Challenges
- Beauty Health price target lowered to $1.50 from $1.75 at Canaccord
- Cautious Hold on Beauty Health Amid Sales Guidance Shortfall and China Execution Risks
- BeautyHealth Reports 2024 Financial Results Amid Challenges
Questions or Comments about the article? Write to editor@tipranks.com